Novo Nordisk recently released their oral version of their GLP-1 agonist Ozempic/Semaglutide. It is a daily oral pill designed to treat type 2 diabetes







The weight loss pill has finally landed. Rybelsus [kaD-TnpOEYj]

The weight loss pill has finally landed. Rybelsus [kaD-TnpOEYj]

| 1h 28m 28s | Video has closed captioning.

Novo Nordisk recently released their oral version of their GLP-1 agonist Ozempic/Semaglutide. It is a daily oral pill designed to treat type 2 diabetes but the hormone the medication mimics also has a god weight loss effect. The injectable versions of GLP-1 agonists are demonstrating terrific weight loss effects. How does Rybelsus stack up. Watch and find out.

Aired: December 12, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now